Planet 13 Holdings (PLNH) Notes Payables (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Notes Payables came in at $9.8 million in Q1 2026, up 10.2% year-on-year from $8.8 million in Q1 2025, and little changed on a QoQ basis from $9.8 million in Q4 2025.
Planet 13 Holdings (PLNH) Notes Payables (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Notes Payables data on file, last reported at $9.8 million in Q1 2026.
- On a quarterly basis, Notes Payables rose 10.2% year-over-year to $9.8 million in Q1 2026; TTM through Mar 2026 was $9.8 million, a 10.2% increase from a year earlier, with the FY2025 full-year figure at $9.8 million, up 12.31% from the prior year.
- Notes Payables for Q1 2026 stood at $9.8 million, roughly flat from $9.8 million in the prior quarter.
- Over the last five years, Notes Payables for PLNH reached as high as $10.6 million in Q2 2025 and fell as low as $884000.0 in Q1 2022.
- Historically, Notes Payables has averaged $5.1 million across 5 years, with a median of $884000.0 in 2022.
- Across the five-year window, Notes Payables changed 0.0% in 2022 and soared 1068.74% in 2024, its largest moves.
- Year by year, Notes Payables stood at $884000.0 in 2022, then changed by 0.0% to $884000.0 in 2023, then jumped by 882.09% to $8.7 million in 2024, then climbed by 12.31% to $9.8 million in 2025, then changed by 0.0% to $9.8 million in 2026.
- Per Business Quant data, the three most recent Notes Payables figures were $9.8 million in Q1 2026, $9.8 million in Q4 2025, and $10.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.75 Mn |
| Dec 31, 2025 | 9.75 Mn |
| Sep 30, 2025 | 10.63 Mn |
| Jun 30, 2025 | 10.63 Mn |
| Mar 31, 2025 | 8.85 Mn |
| Dec 31, 2024 | 8.68 Mn |
| Sep 30, 2024 | 10.33 Mn |
| Jun 30, 2024 | 10.33 Mn |
| Mar 31, 2024 | 884,000.00 |
| Dec 31, 2023 | 884,000.00 |
| Sep 30, 2023 | 884,000.00 |
| Jun 30, 2023 | 884,000.00 |
| Mar 31, 2023 | 884,000.00 |
| Dec 31, 2022 | 884,000.00 |
| Sep 30, 2022 | 884,000.00 |
| Jun 30, 2022 | 884,000.00 |
| Mar 31, 2022 | 884,000.00 |
| Dec 31, 2021 | 884,000.00 |